DAVITA INC (DVA) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:DVA - US23918K1088 - Common Stock
101.71 USD
-2.76 (-2.64%)
Overall DVA gets a fundamental rating of 5 out of 10. We evaluated DVA against 100 industry peers in the Health Care Providers & Services industry. DVA has an excellent profitability rating, but there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on DVA.
1. Profitability
1.1 Basic Checks
- In the past year DVA was profitable.
- DVA had a positive operating cash flow in the past year.
- In the past 5 years DVA has always been profitable.
- DVA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- DVA's Return On Assets of 4.40% is fine compared to the rest of the industry. DVA outperforms 72.00% of its industry peers.
- DVA has a Return On Invested Capital of 10.88%. This is amongst the best in the industry. DVA outperforms 82.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for DVA is in line with the industry average of 9.19%.
- The last Return On Invested Capital (10.88%) for DVA is above the 3 year average (9.26%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | N/A | ||
| ROIC | 10.88% |
ROA(3y)4.27%
ROA(5y)4.62%
ROE(3y)305.73%
ROE(5y)220.5%
ROIC(3y)9.26%
ROIC(5y)9.4%
1.3 Margins
- Looking at the Profit Margin, with a value of 5.80%, DVA belongs to the top of the industry, outperforming 81.00% of the companies in the same industry.
- DVA's Profit Margin has been stable in the last couple of years.
- With an excellent Operating Margin value of 14.57%, DVA belongs to the best of the industry, outperforming 87.00% of the companies in the same industry.
- DVA's Operating Margin has been stable in the last couple of years.
- DVA has a Gross Margin of 31.98%. This is in the better half of the industry: DVA outperforms 61.00% of its industry peers.
- DVA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.57% | ||
| PM (TTM) | 5.8% | ||
| GM | 31.98% |
OM growth 3Y0.04%
OM growth 5Y-0.21%
PM growth 3Y-4.61%
PM growth 5Y0.51%
GM growth 3Y1.6%
GM growth 5Y1.53%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DVA is still creating some value.
- DVA has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, DVA has less shares outstanding
- The debt/assets ratio for DVA is higher compared to a year ago.
2.2 Solvency
- DVA has an Altman-Z score of 1.61. This is a bad value and indicates that DVA is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 1.61, DVA is doing worse than 62.00% of the companies in the same industry.
- DVA has a debt to FCF ratio of 7.93. This is a slightly negative value and a sign of low solvency as DVA would need 7.93 years to pay back of all of its debts.
- DVA has a Debt to FCF ratio of 7.93. This is comparable to the rest of the industry: DVA outperforms 55.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.93 | ||
| Altman-Z | 1.61 |
ROIC/WACC1.31
WACC8.3%
2.3 Liquidity
- A Current Ratio of 1.36 indicates that DVA should not have too much problems paying its short term obligations.
- DVA has a Current ratio (1.36) which is in line with its industry peers.
- DVA has a Quick Ratio of 1.32. This is a normal value and indicates that DVA is financially healthy and should not expect problems in meeting its short term obligations.
- DVA has a Quick ratio of 1.32. This is comparable to the rest of the industry: DVA outperforms 52.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
- DVA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.94%.
- DVA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.47% yearly.
- DVA shows a small growth in Revenue. In the last year, the Revenue has grown by 5.14%.
- The Revenue has been growing slightly by 2.39% on average over the past years.
EPS 1Y (TTM)3.94%
EPS 3Y1.41%
EPS 5Y11.47%
EPS Q2Q%-18.4%
Revenue 1Y (TTM)5.14%
Revenue growth 3Y3.32%
Revenue growth 5Y2.39%
Sales Q2Q%4.8%
3.2 Future
- Based on estimates for the next years, DVA will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.39% on average per year.
- DVA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.81% yearly.
EPS Next Y12.69%
EPS Next 2Y15.96%
EPS Next 3Y16.78%
EPS Next 5Y14.39%
Revenue Next Year5.89%
Revenue Next 2Y4.42%
Revenue Next 3Y4.2%
Revenue Next 5Y4.81%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 11.02, the valuation of DVA can be described as very reasonable.
- Compared to the rest of the industry, the Price/Earnings ratio of DVA indicates a rather cheap valuation: DVA is cheaper than 89.00% of the companies listed in the same industry.
- DVA is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 7.96, the valuation of DVA can be described as very cheap.
- DVA's Price/Forward Earnings ratio is rather cheap when compared to the industry. DVA is cheaper than 96.00% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of DVA to the average of the S&P500 Index (24.04), we can say DVA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.02 | ||
| Fwd PE | 7.96 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, DVA is valued cheaply inside the industry as 89.00% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, DVA is valued cheaper than 96.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.56 | ||
| EV/EBITDA | 6.38 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of DVA may justify a higher PE ratio.
- A more expensive valuation may be justified as DVA's earnings are expected to grow with 16.78% in the coming years.
PEG (NY)0.87
PEG (5Y)0.96
EPS Next 2Y15.96%
EPS Next 3Y16.78%
5. Dividend
5.1 Amount
- No dividends for DVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:DVA (1/14/2026, 2:54:40 PM)
101.71
-2.76 (-2.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners51.6%
Inst Owner Change0.22%
Ins Owners4.68%
Ins Owner Change-0.22%
Market Cap7.18B
Revenue(TTM)13.32B
Net Income(TTM)771.91M
Analysts52.94
Price Target141.36 (38.98%)
Short Float %20.5%
Short Ratio7.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.57%
Min EPS beat(2)-37.31%
Max EPS beat(2)4.17%
EPS beat(4)3
Avg EPS beat(4)-6.79%
Min EPS beat(4)-37.31%
Max EPS beat(4)4.29%
EPS beat(8)5
Avg EPS beat(8)-2.85%
EPS beat(12)8
Avg EPS beat(12)-0.85%
EPS beat(16)10
Avg EPS beat(16)-2.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)-0.43%
Revenue beat(4)0
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)-0.01%
Revenue beat(8)3
Avg Revenue beat(8)0.18%
Revenue beat(12)6
Avg Revenue beat(12)0.26%
Revenue beat(16)7
Avg Revenue beat(16)-0.21%
PT rev (1m)0%
PT rev (3m)-9.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.02 | ||
| Fwd PE | 7.96 | ||
| P/S | 0.54 | ||
| P/FCF | 5.56 | ||
| P/OCF | 3.79 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.38 |
EPS(TTM)9.23
EY9.07%
EPS(NY)12.77
Fwd EY12.56%
FCF(TTM)18.3
FCFY18%
OCF(TTM)26.82
OCFY26.37%
SpS188.64
BVpS-8.1
TBVpS-118.07
PEG (NY)0.87
PEG (5Y)0.96
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | N/A | ||
| ROCE | 13.34% | ||
| ROIC | 10.88% | ||
| ROICexc | 11.46% | ||
| ROICexgc | 26.19% | ||
| OM | 14.57% | ||
| PM (TTM) | 5.8% | ||
| GM | 31.98% | ||
| FCFM | 9.7% |
ROA(3y)4.27%
ROA(5y)4.62%
ROE(3y)305.73%
ROE(5y)220.5%
ROIC(3y)9.26%
ROIC(5y)9.4%
ROICexc(3y)9.63%
ROICexc(5y)9.74%
ROICexgc(3y)20.96%
ROICexgc(5y)20.57%
ROCE(3y)11.35%
ROCE(5y)11.54%
ROICexgc growth 3Y9.54%
ROICexgc growth 5Y5.46%
ROICexc growth 3Y5.31%
ROICexc growth 5Y2.72%
OM growth 3Y0.04%
OM growth 5Y-0.21%
PM growth 3Y-4.61%
PM growth 5Y0.51%
GM growth 3Y1.6%
GM growth 5Y1.53%
F-Score5
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.93 | ||
| Debt/EBITDA | 3.85 | ||
| Cap/Depr | 85.53% | ||
| Cap/Sales | 4.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.64% | ||
| Profit Quality | 167.42% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z | 1.61 |
F-Score5
WACC8.3%
ROIC/WACC1.31
Cap/Depr(3y)78.43%
Cap/Depr(5y)87.31%
Cap/Sales(3y)4.74%
Cap/Sales(5y)5.11%
Profit Quality(3y)181.3%
Profit Quality(5y)168.85%
High Growth Momentum
Growth
EPS 1Y (TTM)3.94%
EPS 3Y1.41%
EPS 5Y11.47%
EPS Q2Q%-18.4%
EPS Next Y12.69%
EPS Next 2Y15.96%
EPS Next 3Y16.78%
EPS Next 5Y14.39%
Revenue 1Y (TTM)5.14%
Revenue growth 3Y3.32%
Revenue growth 5Y2.39%
Sales Q2Q%4.8%
Revenue Next Year5.89%
Revenue Next 2Y4.42%
Revenue Next 3Y4.2%
Revenue Next 5Y4.81%
EBIT growth 1Y2.94%
EBIT growth 3Y3.37%
EBIT growth 5Y2.18%
EBIT Next Year42.6%
EBIT Next 3Y15.11%
EBIT Next 5Y11.57%
FCF growth 1Y-1.7%
FCF growth 3Y4.39%
FCF growth 5Y-3.25%
OCF growth 1Y-1.26%
OCF growth 3Y1.55%
OCF growth 5Y-4.13%
DAVITA INC / DVA FAQ
What is the ChartMill fundamental rating of DAVITA INC (DVA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to DVA.
What is the valuation status of DAVITA INC (DVA) stock?
ChartMill assigns a valuation rating of 8 / 10 to DAVITA INC (DVA). This can be considered as Undervalued.
Can you provide the profitability details for DAVITA INC?
DAVITA INC (DVA) has a profitability rating of 7 / 10.
How financially healthy is DAVITA INC?
The financial health rating of DAVITA INC (DVA) is 3 / 10.
What is the expected EPS growth for DAVITA INC (DVA) stock?
The Earnings per Share (EPS) of DAVITA INC (DVA) is expected to grow by 12.69% in the next year.